Study supports shorter chlorhexidine shampoo contact time in dogs
Bottom line
A new open-access study in Veterinary Dermatology evaluated a 3% chlorhexidine/ophytrium shampoo and mousse in 18 healthy dogs and found that both formulations inhibited growth of common canine bacterial and fungal pathogens in vitro, including methicillin-susceptible and methicillin-resistant Staphylococcus pseudintermedius, E. coli, ESBL-producing E. coli, Pseudomonas aeruginosa, and Malassezia pachydermatis. The shampoo’s antimicrobial activity after a 3-minute contact time was non-inferior to 10 minutes, and the leave-on mousse showed residual activity for at least four days against most tested organisms. The products studied align with Ceva’s DOUXO S3 PYO formulation, which is labeled with 3% chlorhexidine digluconate and 0.5% ophytrium. (researchgate.net)
Why it matters: For veterinary teams managing canine pyoderma and skin dysbiosis, the study adds bench evidence supporting shorter shampoo contact times and the potential value of leave-on antiseptic therapy between baths. That matters because current ISCAID guidance says topical antimicrobial therapy alone is the treatment of choice for surface and superficial pyodermas, and notes that 2% to 4% chlorhexidine products have the strongest clinical support. In practice, anything that may improve pet parent adherence without sacrificing activity could help reduce reliance on systemic antimicrobials. (amrvetcollective.com)
What to watch: The next question is whether these in vitro findings translate into better real-world adherence, lesion resolution, and antimicrobial stewardship outcomes in dogs with active disease. (researchgate.net)
A newly published study in Veterinary Dermatology reports that a 3% chlorhexidine/ophytrium shampoo and mousse both showed in vitro antimicrobial activity against a range of common canine skin pathogens, with one especially practical finding for clinics and pet parents: a 3-minute shampoo contact time performed as well as 10 minutes, and the leave-on mousse maintained residual activity for at least four days against most tested isolates. The study included hair samples from 18 healthy dogs and tested activity against MSSP, MRSP, E. coli, ESBL-producing E. coli, Pseudomonas aeruginosa, and Malassezia pachydermatis. (researchgate.net)
The work lands at a time when veterinary dermatology is increasingly focused on topical-first management of superficial infections. The latest ISCAID canine pyoderma guidance states that topical antimicrobial therapy alone is the treatment of choice for surface and superficial pyodermas, while systemic antimicrobials should generally be reserved for deep pyoderma or cases where topical care is not feasible or not effective enough. The same guideline says chlorhexidine products in the 2% to 4% range have the strongest support for efficacy in canine pyoderma. (amrvetcollective.com)
In the new study, dogs were treated once with shampoo for 3, 5, or 10 minutes, or once with mousse, then hair samples were collected and placed on agar inoculated with target organisms. Investigators found no significant differences between shampoo contact times for any isolate, supporting their non-inferiority hypothesis for a 3-minute wash. For the mousse, growth inhibition versus negative controls was significant on day 0, day 2, and day 4 for all isolates, and the authors concluded residual activity persisted for at least four days for MSSP, MRSP, E. coli, P. aeruginosa, and M. pachydermatis. (researchgate.net)
The formulation itself is commercially relevant. DailyMed labeling for DOUXO S3 PYO shampoo lists 3% chlorhexidine digluconate and 0.5% ophytrium, and indicates use in dogs or cats with bacterial or yeast skin infections responsive to chlorhexidine. The shampoo label directs a 5- to 10-minute contact time before rinsing, while also suggesting the mousse as a leave-on option. That makes the study notable not because it changes a label, but because it may inform how clinicians think about practical use and compliance in the exam room. (dailymed.nlm.nih.gov)
There wasn’t much independent expert reaction available in public sources yet, but the broader field has been moving in the same direction. Earlier clinical research on related 3% chlorhexidine/ophytrium products found that daily antiseptic pads improved focal bacterial and Malassezia overgrowth over 14 days, with high veterinarian and pet parent satisfaction. Taken together, that suggests growing interest in delivery formats that make topical antiseptic therapy easier to continue at home, especially for localized disease or maintenance between baths. That’s an inference based on the pattern across studies, rather than a direct claim from any one paper. (frontiersin.org)
Why it matters: For veterinary professionals, the biggest takeaway is operational. Compliance is often the weak point in topical therapy, especially when shampoo protocols require long contact times or frequent full-body bathing. If a shorter contact time can preserve antimicrobial effect, and if a leave-on mousse can extend activity for several days, clinics may have more flexibility when building protocols for superficial pyoderma, recurrent dysbiosis, or cases where pet parent bandwidth is limited. That fits squarely with stewardship goals, because current guidelines emphasize cytology before antimicrobials, topical therapy first for superficial disease, and limiting systemic antibiotic use whenever possible. (researchgate.net)
The study also has clear limits. It was an in vitro hair-plating model in healthy dogs, not a clinical outcomes trial in dogs with active pyoderma or Malassezia dermatitis. The sample size was small, group allocation depended partly on owner preference and dog temperament, and the paper does not establish that a 3-minute bath is clinically equivalent to longer contact times across all real-world cases. So the findings are useful and practical, but they should be read as supportive evidence, not as a replacement for cytology, diagnosis of underlying disease, or follow-up assessment. (researchgate.net)
What to watch: Watch for follow-up clinical trials in dogs with active infection, especially studies measuring lesion resolution, recurrence, pet parent adherence, and whether leave-on chlorhexidine/ophytrium protocols can help reduce systemic antibiotic use in routine practice. (researchgate.net)